Navigation Links
GlaxoSmithKline Defends Its Products

Pharmaceutical company GlaxoSmithKline which produces Panadol products like Panadol Extra has sought to dispel doubts with regard to the safety of its products. People in the Middle East Region // are reported to have received messages questioning the safety with regard to particular batch of its products, namely batch number 050292.

The company has confirmed the safety of the products after retesting the batch at its own and other independent laboratories. Information with regard to this has also been passed on to the concerned governments, according to company sources. The company had initiated the investigations as the allegations made against the medicines were of a serious nature.

The company has not however questioned the motives of the people who are forwarding the messages, stating that they may have done so with the best of intentions, even though based on false information. The company insists that it has been enjoying an unsullied reputation for over half a century.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline launches diabetes and cancer drugs
6. Generic Products Compete With GlaxoSmithKline
7. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
8. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
9. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
10. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
11. GlaxoSmithKline Signs Outsourcing Deal With TCS

Post Your Comments:
(Date:11/7/2009)...,, HOUSTON, Nov. 7 T...ented Lisa James, Director of Health at the Family...istinguished Service today at its semi-annual poli... Service is the highest honor the AMA House of Del... http://www.newscom.com/cgi-bin/prnh/20081209/AM...
(Date:11/7/2009)...,, HOUSTON, Nov. 7 Calling this...ciation (AMA), the AMA President J. James Rohack, ...physicians from all state and medical specialty so...licy-making meeting, where health system reform wi...om.com/cgi-bin/prnh/20081209/AMALOGO ) ,, "Ov...
(Date:11/7/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -...earing, antichoice extremists are holding the enti...da. They are demanding that the bill go far beyond...been incorporated into the original bill. In an o... on early Saturday afternoon, antichoice Democrats...
(Date:11/7/2009)...,, WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -... House of Representatives to vote for the Stupak-E..., "The Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Li...federal law on abortion funding and conscience pro... Act (H.R. 3962)," they said. ,, The letter was...
(Date:11/7/2009)...WASHINGTON, Nov. 7 Americans United for Life Acti... the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipi... federal money from going to abortion in health ca...resident and CEO Dr. Charmaine Yoest said, "Americ...tupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-S...
Breaking Medicine News(10 mins):Health News:AMA Honors Family Violence Prevention Expert 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2Health News:Bishops Urge Passage of Stupak-Ellsworth Anti-Abortion Amendment for Health Reform Bill 2Health News:Americans United for Life Action Endorses a Vote for the Stupak-Ellsworth-Pitts-Kaptur-Dahlkemper-Lipinski-Smith Amendment and Sends Score Letter to House Members 2
... Bulletin Board: SCIE), a San Diego based medical ...ished a distribution partnership for the Greek and.... , an Athens-based firm specializing in the marke...another distribution partner in Europe. M.S. Jaco...
...nal, Inc. (NYSE: WTW ) will host a meeting for i...arch 5th in New York City. The purpose of this mee...erations and initiatives. , , Presentations are e...ebsite, www.weightwatchersinternational.com . A r...
... Inc. (NYSE: HRC ) today announced its fiscal 20...his dividend was declared by Hill-Rom,s Board of D...arch 31, 2009 to shareholders of record as of Marc...rvices for the health care industry, including pat...
...s, study finds, , , FRIDAY, Feb. 13 (Healt... reduce catheter-related blood clots in cancer pat...s complication, says a U.K. study. , About 50 per...eliver infusional chemotherapy, according to backg...
...r to read than women,s, speed-dating study finds ,...you,re unattached this Valentine,s Day and you,re ...latest scientific discovery: Apparently, it,s easi...re obvious and straightforward about that fact tha...
...NYSE Alternext: FHC) announced today that its stoc...0 shares and extended until December 31, 2010. The...se up to 1,000,000 shares of the Company,s common ... 2009, the Company had repurchased nearly 1.6 mill...
Other Medicine News:Health News:SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus 2Health News:SpectraScience Secures Distribution for WavSTAT(R) Cancer Diagnosis System in Greece & Cyprus 3Health News:Weight Watchers to Host Investor Meeting 2Health News:New Anti-Clotting Treatment Urged for Cancer Patients 2Health News:Men, the Obvious Sex 2Health News:Men, the Obvious Sex 3Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 2Health News:The Female Health Company Expands and Extends Its Stock Repurchase Program 3
(Date:11/6/2009)..., DURHAM, N.C., Nov. 6 ...OXBO) today announced that a previously approved r...at the start of trading on Monday, Nov. 9, 2009 on...eutics, Inc. shares will trade under the new symbo...r, 69207P 20 9, when the split becomes effective. ...
(Date:11/6/2009)..., WILMINGTON, Mass., Nov. 6 /PRNewswire-FirstCall...: DUSA), a dermatology company that is developing ... (PDT) and other products focused on patients with... President and Chief Executive Officer, will prese...d Investor Summit 2009 on Tuesday, November 10, 20...
(Date:11/6/2009)..., OAKLAND, Calif., Nov. 6 Kaiser ...spitals (KFHP/H), and their subsidiaries reported ...billion for the quarter ended September 30, 2009, ...last year. Operating income in the third quarter w...hird quarter of last year. Net non-operating incom...
Breaking Medicine Technology:Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 2Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Skin disease patients show brain immunity to faces of disgust 55521 1Skin disease patients show brain immunity to faces of disgust 55521 2Small rodents encourage the formation of scrubland in Spain 9717 1Small rodents encourage the formation of scrubland in Spain 9717 2Beta blockers and stroke new insights into their use for older people 9715 1Beta blockers and stroke new insights into their use for older people 9715 2
..., CAMBRIDGE, Mass. and LONDON, Feb. 6 Idenix Phar...Kline (GSK) today announced the execution of a lic...ghts to IDX899. IDX899 is a novel non-nucleoside ...I clinical development being developed by Idenix f...ed to address the increasing prevalence of viral r...
..., Journal of American College of Cardiology publis...., Feb. 5 Boston Scientific Corporation (NYSE: ... U.S. Food and Drug Administration (FDA) the final...) applications for both its TAXUS(R) Liberte(R) At...d its TAXUS Liberte Long(TM) Paclitaxel-Eluting Co...
Other Medicine Technology:Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 2Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 3Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 4Idenix Pharmaceuticals and GlaxoSmithKline Sign Worldwide License Agreement for IDX899, a Novel NNRTI for the Treatment of HIV 5Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 2Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 3Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 4Boston Scientific Submits Final Modules to FDA for Approval of Second-Generation Small Vessel and Long Lesion Stents 5
Dodick-Kammann Nucleus Chopper
Chang Phaco Chopper
Denman Brown Nucleus Cracker
Forceps Epilation Angled End B510.10 3.5"
Medicine Products: